Bắt đầu
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

Không có giao dịch
Xem siêu biểu đồ
Tổng quan Tài chính Ý tưởng Thảo luận Kỹ thuật Dự đoán Các chỉ số có tính thời vụ
Trái phiếu

Trái phiếu 4AB

Sau đây là danh sách trái phiếu doanh nghiệp ABBVIE INC. Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Mã
Lợi suất đáo hạn %
Khối lượng
Giá %
Phiếu giảm giá %
Ngày đáo hạn
Giá trị dư nợ
Giá trị khuôn mặt
Giá trị mệnh giá tối thiểu
Bên phát hành
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6.57%600 K84.44%4.55%2035-03-15107.646 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.56%15 K79.63%4.85%2044-06-1565.232 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6.44%10 K79.20%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.31%5 K80.72%4.63%2042-10-0167.493 M USD1,000.00 USD2,000.00 USDActavis, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.71%50 K89.00%3.20%2029-11-2162.515 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.59%10 M98.36%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.54%089.07%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.51%10.452 M98.14%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5.50%085.80%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.49%100 K98.22%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.49%15 K91.11%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.46%90 K90.75%4.75%2045-03-15827.091 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.44%200 K90.15%4.63%2042-10-01389.217 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.43%1.115 M87.53%4.40%2042-11-062.599 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.42%3.947 M92.69%4.85%2044-06-151.008 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.41%25.585 M82.73%4.25%2049-11-215.745 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.37%3.715 M85.88%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5.25%091.57%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5.20%094.24%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5.19%228 K94.78%4.55%2035-03-151.681 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5.10%54 K99.62%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.98%3.28 M99.84%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.81%1.531 M92.80%3.20%2029-11-215.437 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.79%317 K100.04%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4.76%099.06%3.80%2025-03-15130.225 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4.75%096.53%2.95%2026-11-219.245 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.67%287 K98.45%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.66%2.98 M100.32%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.64%097.92%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.61%70 K96.80%2.95%2026-11-213.991 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.33%099.29%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4.12%605 K99.68%3.80%2025-03-152.889 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3.78%095.69%2.63%2028-11-1572.107 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3.77%093.12%2.13%2029-06-0136.462 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.07%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.03%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.96%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2.89%089.58%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2.77%097.23%2.13%2029-06-01506.088 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.75%099.53%2.63%2028-11-15427.793 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2.68%097.89%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2.64%1.366 M99.96%2.60%2024-11-213.739 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2.52%094.87%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.01%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1.63%0102.15%3.80%2025-03-151.268 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3.63%0106.34%2.60%2024-11-2110.86 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.